CanSino Biologics Inc. (CASBF)
OTCMKTS · Delayed Price · Currency is USD
3.200
-1.400 (-30.43%)
At close: Apr 9, 2025

CanSino Biologics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-220.33-378.88-1,483-909.431,914-396.64
Upgrade
Depreciation & Amortization
195.25195.25263.24189.2273.3624.59
Upgrade
Other Amortization
21.5821.586.37.1415.187.22
Upgrade
Loss (Gain) From Sale of Assets
0.020.02-0.02---
Upgrade
Asset Writedown & Restructuring Costs
1.321.32362.70.250.250.53
Upgrade
Loss (Gain) From Sale of Investments
43.143.1-42.63-76.63-71.86-38.68
Upgrade
Stock-Based Compensation
3.23.29.5410.089.8-
Upgrade
Provision & Write-off of Bad Debts
15.1515.1515.058.781.82-
Upgrade
Other Operating Activities
-3.8960.26139.98624.87-6.5843.5
Upgrade
Change in Accounts Receivable
-78.56-78.56265.97-495.8-419.94-107.76
Upgrade
Change in Inventory
-0.68-0.68-216.54-604.02-706.39-154.57
Upgrade
Change in Accounts Payable
-106.27-106.27-223.19-429.931,212155.58
Upgrade
Change in Unearned Revenue
54.3854.38-5.6420.8827.52-
Upgrade
Change in Other Net Operating Assets
0.380.3811.2--2.11
Upgrade
Operating Cash Flow
-72.89-167.29-908.23-1,8522,050-349.93
Upgrade
Capital Expenditures
-390.59-457.64-610.47-1,075-1,203-288.29
Upgrade
Sale of Property, Plant & Equipment
0.040.040.31---
Upgrade
Cash Acquisitions
-1.31-1.31-0.34---
Upgrade
Investment in Securities
149.22377.4899.25-697.83-1,403-60.06
Upgrade
Other Investing Activities
-467.2883.8961.59545.2145.7728.66
Upgrade
Investing Cash Flow
-709.912.46-449.65-1,228-2,560-319.69
Upgrade
Short-Term Debt Issued
--50.46---
Upgrade
Long-Term Debt Issued
-1,0431,6352,6341,150-
Upgrade
Total Debt Issued
1,0161,0431,6852,6341,150-
Upgrade
Short-Term Debt Repaid
---20.58---
Upgrade
Long-Term Debt Repaid
--1,314-1,615-1,388-181-22.49
Upgrade
Total Debt Repaid
-1,484-1,314-1,636-1,388-181-22.49
Upgrade
Net Debt Issued (Repaid)
-468.17-270.4749.321,246969.13-22.49
Upgrade
Issuance of Common Stock
--16.98--4,984
Upgrade
Repurchase of Common Stock
----150.17--
Upgrade
Common Dividends Paid
-60.02-63.78-73.75-241.28-14.1-6.69
Upgrade
Other Financing Activities
0.270.07-0.14-0.37598.59-13.55
Upgrade
Financing Cash Flow
-527.92-334.18-7.58854.231,5544,941
Upgrade
Foreign Exchange Rate Adjustments
-8.518.7220.29160.76-33.78-27.36
Upgrade
Net Cash Flow
-1,319-490.29-1,345-2,0641,0094,244
Upgrade
Free Cash Flow
-463.48-624.93-1,519-2,927846.86-638.23
Upgrade
Free Cash Flow Margin
-53.32%-73.84%-425.31%-282.87%19.70%-2564.19%
Upgrade
Free Cash Flow Per Share
-1.90-2.52-6.16-11.843.42-2.77
Upgrade
Cash Income Tax Paid
52.8925.19-24.05-77.91-162.45-5.99
Upgrade
Levered Free Cash Flow
98.34-860.93-908.45-2,557185.99-556.69
Upgrade
Unlevered Free Cash Flow
134.79-823.44-868.36-2,531198.76-556.69
Upgrade
Change in Net Working Capital
-483.35348.72-539.59725.28-188.51-5.81
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.